185 related articles for article (PubMed ID: 8713090)
21. Developmental changes in glycolipid synthesizing enzymes in the brain of a myelin-deficient mutant Wistar rat.
Hof L; Csiza CK
J Neurochem; 1982 Nov; 39(5):1434-9. PubMed ID: 6214615
[TBL] [Abstract][Full Text] [Related]
22. Hypoxic injury to oligodendrocytes: reversible inhibition of ATP-dependent transport of ceramide from the endoplasmic reticulum to the Golgi.
Kendler A; Dawson G
J Neurosci Res; 1992 Feb; 31(2):205-11. PubMed ID: 1573674
[TBL] [Abstract][Full Text] [Related]
23. Drastically abnormal gluco- and galactosylceramide composition does not affect ganglioside metabolism in the brain of mice deficient in galactosylceramide synthase.
Suzuki K; Vanier MT; Coetzee T; Popko B
Neurochem Res; 1999 Apr; 24(4):471-4. PubMed ID: 10227678
[TBL] [Abstract][Full Text] [Related]
24. 3-O-acetyl-sphingosine-series myelin glycolipids: characterization of novel 3-O-acetyl-sphingosine galactosylceramide.
Dasgupta S; Levery SB; Hogan EL
J Lipid Res; 2002 May; 43(5):751-61. PubMed ID: 11971946
[TBL] [Abstract][Full Text] [Related]
25. A mammalian fatty acid hydroxylase responsible for the formation of alpha-hydroxylated galactosylceramide in myelin.
Eckhardt M; Yaghootfam A; Fewou SN; Zöller I; Gieselmann V
Biochem J; 2005 May; 388(Pt 1):245-54. PubMed ID: 15658937
[TBL] [Abstract][Full Text] [Related]
26. Arabidopsis galactolipid biosynthesis and lipid trafficking mediated by DGD1.
Dörmann P; Balbo I; Benning C
Science; 1999 Jun; 284(5423):2181-4. PubMed ID: 10381884
[TBL] [Abstract][Full Text] [Related]
27. Molecular cloning of a rat brain cDNA, with homology to a tyrosine kinase substrate, that induces galactosylceramide expression in COS-7 cells.
Ogura K; Kohno K; Tai T
J Neurochem; 1998 Nov; 71(5):1827-36. PubMed ID: 9798906
[TBL] [Abstract][Full Text] [Related]
28. Activation of UDP-galactose:globotriaosylceramide alpha 1-3-galactosyltransferase during PC12D cell differentiation induced by galactosylceramide.
Ariga T; Yoshino H; Ren S; Pal S; Katoh-Semba R; Yu RK
Biochemistry; 1993 Aug; 32(31):7904-8. PubMed ID: 8347595
[TBL] [Abstract][Full Text] [Related]
29. Isolation, characterization, and expression of cDNA clones that encode rat UDP-galactose: ceramide galactosyltransferase.
Stahl N; Jurevics H; Morell P; Suzuki K; Popko B
J Neurosci Res; 1994 Jun; 38(2):234-42. PubMed ID: 7521399
[TBL] [Abstract][Full Text] [Related]
30. The PGRMC1 Antagonist AG-205 Inhibits Synthesis of Galactosylceramide and Sulfatide.
Wang-Eckhardt L; Becker I; Eckhardt M
Cells; 2021 Dec; 10(12):. PubMed ID: 34944026
[TBL] [Abstract][Full Text] [Related]
31. Exposure of galactosylceramide to galactose oxidase in liposomes: dependence on lipid environment and ceramide composition.
Stewart RJ; Boggs JM
Biochemistry; 1993 Jun; 32(21):5605-14. PubMed ID: 8504080
[TBL] [Abstract][Full Text] [Related]
32. FA2H is responsible for the formation of 2-hydroxy galactolipids in peripheral nervous system myelin.
Maldonado EN; Alderson NL; Monje PV; Wood PM; Hama H
J Lipid Res; 2008 Jan; 49(1):153-61. PubMed ID: 17901466
[TBL] [Abstract][Full Text] [Related]
33. Lead exposure affects levels of galactolipid metabolic enzymes in the developing rat brain.
Deng W; Poretz RD
Toxicol Appl Pharmacol; 2001 Apr; 172(2):98-107. PubMed ID: 11298496
[TBL] [Abstract][Full Text] [Related]
34. Axonal regulation of Schwann cell glycolipid biosynthesis.
Yao JK; Windebank AJ; Poduslo JF; Yoshino JE
Neurochem Res; 1990 Mar; 15(3):279-82. PubMed ID: 2366930
[TBL] [Abstract][Full Text] [Related]
35. Substrate reduction therapy for Krabbe disease and metachromatic leukodystrophy using a novel ceramide galactosyltransferase inhibitor.
Babcock MC; Mikulka CR; Wang B; Chandriani S; Chandra S; Xu Y; Webster K; Feng Y; Nelvagal HR; Giaramita A; Yip BK; Lo M; Jiang X; Chao Q; Woloszynek JC; Shen Y; Bhagwat S; Sands MS; Crawford BE
Sci Rep; 2021 Jul; 11(1):14486. PubMed ID: 34262084
[TBL] [Abstract][Full Text] [Related]
36. Cloning, characterization, and expression of human ceramide galactosyltransferase cDNA.
Kapitonov D; Yu RK
Biochem Biophys Res Commun; 1997 Mar; 232(2):449-53. PubMed ID: 9125199
[TBL] [Abstract][Full Text] [Related]
37. Monoclonal antibody to galactosylceramide: discrimination of structural difference in the ceramide moiety.
Nakakuma H; Arai M; Kawaguchi T; Horikawa K; Hidaka M; Sakamoto K; Iwamori M; Nagai Y; Takatsuki K
FEBS Lett; 1989 Dec; 258(2):230-2. PubMed ID: 2480915
[TBL] [Abstract][Full Text] [Related]
38. GM1 synthase depends on N-glycosylation for enzyme activity and trafficking to the Golgi complex.
Martina JA; Daniotti JL; Maccioni HJ
Neurochem Res; 2000 May; 25(5):725-31. PubMed ID: 10905635
[TBL] [Abstract][Full Text] [Related]
39. New perspectives on the function of myelin galactolipids.
Coetzee T; Suzuki K; Popko B
Trends Neurosci; 1998 Mar; 21(3):126-30. PubMed ID: 9530920
[TBL] [Abstract][Full Text] [Related]
40. Functional analysis of a lipid galactosyltransferase synthesizing the major envelope lipid in the Lyme disease spirochete Borrelia burgdorferi.
Ostberg Y; Berg S; Comstedt P; Wieslander A; Bergström S
FEMS Microbiol Lett; 2007 Jul; 272(1):22-9. PubMed ID: 17456185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
